{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:12Z","timestamp":1789632192694,"version":"build-2803163510"},"reference-count":38,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15823","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:06:37Z","timestamp":1787051197000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Effect of perioperative nutritional status, inflammatory response and postoperative chemotherapy on survival after gastrectomy for advanced gastric cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Yoshinori","family":"Fujiwara","sequence":"first","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Higashida","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Kawasaki Medical School Hospital, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Kawasaki Medical School Hospital, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Makieda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kawasaki Medical School Hospital, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kawasaki Medical School Hospital, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yoshimatsu","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Okayama 701\u20110192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"key20260917101308_b1-ol-32-4-15823","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260917101308_b2-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"key20260917101308_b3-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"e3164","DOI":"10.1097\/MD.0000000000003164","article-title":"Sarcopenia is an Independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: Analysis from a large-scale cohort","volume":"95","author":"Zhuang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20260917101308_b4-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.ejso.2016.05.029","article-title":"The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis","volume":"42","author":"Yang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"key20260917101308_b5-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00268-010-0641-y","article-title":"Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?","volume":"34","author":"Crumley","year":"2010","journal-title":"World J Surg"},{"key":"key20260917101308_b6-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10120-017-0744-3","article-title":"Controlling nutritional status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection","volume":"21","author":"Kuroda","year":"2018","journal-title":"Gastric Cancer"},{"key":"key20260917101308_b7-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12885-018-4616-y","article-title":"Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II\u2013III gastric cancer","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Cancer"},{"key":"key20260917101308_b8-ol-32-4-15823","first-page":"15222","article-title":"Modified glasgow prognostic score as a prognostic factor in gastric cancer patients: A systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20260917101308_b9-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"7862469","DOI":"10.1155\/2016\/7862469","article-title":"Can the neutrophil to lymphocyte ratio be used to determine gastric cancer treatment outcomes? A systematic review and meta-analysis","volume":"2016","author":"Sun","year":"2016","journal-title":"Dis Markers"},{"key":"key20260917101308_b10-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.21873\/anticanres.11248","article-title":"Clinical burden of C-reactive protein\/albumin ratio before curative surgery for patients with gastric cancer","volume":"36","author":"Toiyama","year":"2016","journal-title":"Anticancer Res"},{"key":"key20260917101308_b11-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jso.24067","article-title":"Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation?","volume":"112","author":"Saito","year":"2015","journal-title":"J Surg Oncol"},{"key":"key20260917101308_b12-ol-32-4-15823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)","volume":"26","author":"Japanese Gastric Cancer Association","year":"2023","journal-title":"Gastric Cancer"},{"key":"key20260917101308_b13-ol-32-4-15823","article-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2016","edition":"8th edition"},{"key":"key20260917101308_b14-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10353-018-0551-z","article-title":"Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients","volume":"50","author":"Bolliger","year":"2018","journal-title":"Eur Surg"},{"key":"key20260917101308_b15-ol-32-4-15823","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4471-4354-3_3","article-title":"The Clavien-Dindo Classification of Surgical Complications","volume-title":"Treatment of Postoperative Complications After Digestive Surgery","author":"Dindo","year":"2014"},{"key":"key20260917101308_b16-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/014860717800200406","article-title":"Immunological assays as measurements of nutritional status: A review","volume":"2","author":"Miller","year":"1978","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"key20260917101308_b17-ol-32-4-15823","first-page":"38","article-title":"CONUT: A tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ul\u00edbarri","year":"2005","journal-title":"Nutr Hosp"},{"key":"key20260917101308_b18-ol-32-4-15823","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"key20260917101308_b19-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20260917101308_b20-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","article-title":"S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial","volume":"9","author":"Koizumi","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20260917101308_b21-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"key20260917101308_b22-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1200\/JCO.18.01138","article-title":"Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: Interim analysis of JACCRO GC-07, a randomized controlled trial","volume":"37","author":"Yoshida","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20260917101308_b23-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20260917101308_b24-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ijbiomac.2021.06.140","article-title":"Serum albumin levels and inflammation","volume":"184","author":"Sheinenzon","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"key20260917101308_b25-ol-32-4-15823","first-page":"19","article-title":"Evaluation of C-reactive protein levels influencing nutritional interventions in patients with preoperative gastrointestinal malignant tumors","volume":"51","author":"Okamoto","year":"2025","journal-title":"Kawasaki Med J"},{"key":"key20260917101308_b26-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.amjsurg.2010.01.030","article-title":"Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma","volume":"201","author":"Nozoe","year":"2011","journal-title":"Am J Surg"},{"key":"key20260917101308_b27-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s13277-011-0285-z","article-title":"Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer","volume":"33","author":"Wang","year":"2012","journal-title":"Tumour Biol"},{"key":"key20260917101308_b28-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bjc.2012.262","article-title":"Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer","volume":"107","author":"Jiang","year":"2012","journal-title":"Br J Cancer"},{"key":"key20260917101308_b29-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjsurg.2011.10.015","article-title":"Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer","volume":"204","author":"Dutta","year":"2012","journal-title":"Am J Surg"},{"key":"key20260917101308_b30-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"e0236445","DOI":"10.1371\/journal.pone.0236445","article-title":"Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"key20260917101308_b31-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"key20260917101308_b32-ol-32-4-15823","article-title":"NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer","volume":"12","author":"National Comprehensive Cancer Network","year":"2024","journal-title":"version 4"},{"key":"key20260917101308_b33-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260917101308_b34-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260917101308_b35-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"40","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"key20260917101308_b36-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"key":"key20260917101308_b37-ol-32-4-15823","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/ol.2017.6286","article-title":"Outcome predictors for patients with stage II\/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy","volume":"14","author":"Fujiwara","year":"2017","journal-title":"Oncol Lett"},{"key":"key20260917101308_b38-ol-32-4-15823","first-page":"1205","article-title":"Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients","volume":"39","author":"Kawabata","year":"2012","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:57Z","timestamp":1789629237000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,18]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15823","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}